Key details High prevalence of injury: Up to 95% of cancer patients undergoing radiotherapy develop some form of skin injury, highlighting a significant unmet medical need. Promising new treatment: A Phase 2 clinical trial has identified a hydrogel containing...
A Milestone Anniversary in Bulgaria Our mission has always been to provide families worldwide with access to the most advanced regenerative medicine and cord blood banking technologies. This month, we are delighted to celebrate a significant milestone in that...
Key details The Burden of Acute Respiratory Distress Syndrome (ARDS): ARDS is a life-threatening condition with a mortality rate of 27-45% that often results in a lengthy recovery period and long-term quality of life issues. Safety Profile: Clinical trials have...
Key details High amputation risk: Diabetic foot ulcers are a serious complication of diabetes, often leading to infection and significantly higher amputation risks compared to the non-diabetic population. Treating the root cause: Unlike standard care, stem cell...
Key details Current limitations: Traditional scar treatments (surgery, gels, steroids) are often only partially effective. Even after treatment, scars frequently remain, presenting aesthetic and functional challenges for patients. New research: A recent review...
Key details New clinical phase: A stem cell therapy called laromestrocel has entered a pivotal Phase 2b clinical trial to treat hypoplastic left heart syndrome (HLHS), a congenital defect where the left heart is severely undeveloped.[1] Standard of care: Treatment for...
